IRCT20120718010324N51 IRCT 2019-11-30 Tabriz University of Medical Sciences The effect of curcumin on metabolic indicators in women with polycystic ovarian syndrome The Effect of Curcumin on Metabolic Indicators in Women with Polycystic Ovarian Syndrome: A Randomized Controlled Clinical Trial 2019-11-20 anticipated 54 Complete https://irct.ir/trial/40597 interventional Randomization: Randomized, Blinding: Triple blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Participants will be assigned into two groups of intervention and control with a block randomization method with an assignment ratio of 1:1. To conceal the allocation, the identical opaque, and numbered sequentially pockets will be used, in which the curcumin capsule or placebo capsule will be put into them. Preparation of pockets will be done by a person not involved in the sampling, data collection and analysis , Blinding description: Participants, researcher and data analyst in this study. The drug and the placebo will be same in appearance (shape, color and odor), and the packaging of drugs will be done by someone who is not involved in the research. 3 polycystic ovary syndrome. Intervention 1: The intervention group receives two oral capsules of curcumin at a dose of 500 mg for 12 weeks. Intervention 2: The control group received two oral capsules daily from 500 mg for 12 weeks. No - There is not a plan to make this available Justification or reason for not sharing IPD is Data of participants are privacy.